Cite
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.
MLA
Røsjø, Egil, et al. “Vitamin D Status and Effect of Interferon-Β1a Treatment on MRI Activity and Serum Inflammation Markers in Relapsing-Remitting Multiple Sclerosis.” Journal of Neuroimmunology, vol. 280, Mar. 2015, pp. 21–28. EBSCOhost, https://doi.org/10.1016/j.jneuroim.2015.02.001.
APA
Røsjø, E., Myhr, K.-M., Løken-Amsrud, K. I., Bakke, S. J., Beiske, A. G., Bjerve, K. S., Hovdal, H., Lilleås, F., Midgard, R., Pedersen, T., Šaltytė Benth, J., Torkildsen, Ø., Wergeland, S., Michelsen, A. E., Aukrust, P., Ueland, T., & Holmøy, T. (2015). Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis. Journal of Neuroimmunology, 280, 21–28. https://doi.org/10.1016/j.jneuroim.2015.02.001
Chicago
Røsjø, Egil, Kjell-Morten Myhr, Kristin I Løken-Amsrud, Søren J Bakke, Antonie G Beiske, Kristian S Bjerve, Harald Hovdal, et al. 2015. “Vitamin D Status and Effect of Interferon-Β1a Treatment on MRI Activity and Serum Inflammation Markers in Relapsing-Remitting Multiple Sclerosis.” Journal of Neuroimmunology 280 (March): 21–28. doi:10.1016/j.jneuroim.2015.02.001.